1320 nm Nd:YAG Laser for Improving the Appearance of Onychomycosis
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this clinical study is to improve the appearance of onychomycosis and morphology of the nail (fungal infection). The researcher can use a light based therapy to gently heat the toenail infected with fungus to improve the appearance of onychomycosis.
| Condition | Intervention | Phase |
|---|---|---|
|
Fungal Nail Infection |
Other: treatment |
Phase 1 |
| Study Type: | Interventional |
| Study Design: | Endpoint Classification: Safety/Efficacy Study Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | A Randomized, Placebo-Controlled Study of the 1320 nm Nd:YAG Laser for Improving the Appearance of Onychomycosis |
- improving fungal nail infection [ Time Frame: 6 months ] [ Designated as safety issue: Yes ]fungal nail
| Enrollment: | 10 |
| Study Start Date: | December 2011 |
| Study Completion Date: | December 2012 |
| Primary Completion Date: | December 2012 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
No Intervention: treatment
1320 nm Nd:YAG Laser for Improving the Appearance of Onychomycosis
|
Other: treatment
CoolTouch CT3 Plus™ laser with the CoolBreeze Zoom handpiece
|
Detailed Description:
Toenail fungus (onychomycosis) is a common fungal infection of the nail that affects roughly 10% of Americans. Onychomycosis may be a precursor to many complications like ulcers, or skin infections, which may rarely result in amputation. Current treatment options have relatively limited long-term success and recurrence is common.
The researcher can determine that the laser therapy can heat the nail and destroy and decrease the fungus infecting the nail to improving the appearance of the nail.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Adult Male/ female has been diagnose with fungal nail infection on both great toenails.
Exclusion Criteria:
- Any other toenail disease including, but not limited to psoriasis, lichen planus, pachyonychia congenita, etc. as determined by the investigator.
- Excessively thick or hypertrophic nails.
- Subjects with diabetes.
- Subjects that are pregnant
- Receipt of any topical therapy for onychomycosis (i.e. antifungal) within 2 weeks of enrollment, systemic therapy for onychomycosis (i.e. antifungal) within 3 months of enrollment, or any other procedures done on the test area within 6 months of enrollment.
- Subjects with impaired immune systems including, but not limited to HIV, transplant patients on immunosuppression, etc.
- Current or history of psychiatric disease that would interfere with ability to comply with the study protocol or give informed consent.
- History of alcohol or drug abuse that would interfere with ability to comply with the study protocol.
Contacts and Locations| United States, California | |
| Beckman Laser Institute | |
| Irvine, California, United States, 92612 | |
| Principal Investigator: | Kristen Kelly, MD | Beckman Laser Institute, UCI |
More Information
No publications provided
| Responsible Party: | University of California, Irvine |
| ClinicalTrials.gov Identifier: | NCT01498393 History of Changes |
| Other Study ID Numbers: | NIH/LAMMP |
| Study First Received: | December 20, 2011 |
| Last Updated: | January 15, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by University of California, Irvine:
|
fungal nail |
Additional relevant MeSH terms:
|
Onychomycosis Tinea Dermatomycoses Skin Diseases, Infectious |
Infection Mycoses Nail Diseases Skin Diseases |
ClinicalTrials.gov processed this record on May 21, 2013